2020 has been a very difficult year, healthcare companies and related industries had to step up. COVID-19 brought about new challenges, challenges that required a strict approach towards healthcare waste management.
Our company, Pleasant Waste Management, has always been committed to preserving the environment for future generations. This approach in healthcare waste management has prepared us for the compliance and care necessary to remove infected waste material according to the highest standards. We understand the critical role that we play in preventing waste material from being exposed and causing further spread.
COVID-19 Treatment Hospitals were established as part of the National Strategy against COVID-19. The hospitals needed partners who shared the same enthusiasm in ensuring the highest standards. Henceforth, our understanding and execution regarding strict adherence to medical waste removal protocols was key to being commissioned as one of the trusted waste removal companies during the pandemic.
Our mission was to prevent further spread from infected waste material by serving the various COVID-19 Hospitals. We had to ensure that the use of proper standards regarding the removal of medical waste material and safely transporting the waste to the incinerator. We took further steps by educating the public through our social media channels about COVID-19 compliance and healthcare, assisting wherever we can to help alleviate the COVID-19 pandemic.
The new standards that we have adopted from the pandemic are now essential procedures in our company. We continue to be vigilant, compliant, and strict in serving various our clientele, the war against COVID-19 and preserving our environment for future generations continues.
A case of reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)has been described in a study published online in The Lancet Infectious Diseases.
Richard L. Tillett, Ph.D., from the University of Nevada, Las Vegas, and colleagues described an investigation of two instances of SARS-CoV-2 infection in a 25-year-old man who presented to health authorities on two occasions with symptoms of viral infection, once in April 2020 and a second time at the end of May and beginning of June 2020.
At each presentation and twice during follow-up, nasopharyngeal swabs were obtained from the patient.
To confirm SARS-CoV-2 infection, nucleic acid amplification testing was conducted. Next-generation sequencing of SARS-CoV-2 extracted from nasopharyngeal swabs was performed.
The researchers found that the patient had two positive tests for SARS-CoV-2 — on April 18, 2020, and June 5, 2020 — and two negative tests during follow-up in May 2020.
Genetically significant differences were seen between each variant associated with each instance of infection in a genomic analysis of SARS-CoV-2. Symptomatically, the second infection was more severe than the first.
“It is important to note this is a singular finding and does not provide
generalizability of this phenomenon,” one co-author said in a statement.
“While more research is needed, the possibility of reinfections could have significant implications for our understanding of COVID-19 immunity, especially in the absence of an effective vaccine.”
REFERENCE:
Tillett et al: Genomic evidence for reinfection with SARS-CoV-2: a case study; https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30764-7/fulltext
Download the App Today!